tiprankstipranks
Invion Advances Innovative Cancer and Disease Therapy
Company Announcements

Invion Advances Innovative Cancer and Disease Therapy

Invion Ltd. (AU:IVX) has released an update.

Don't Miss Our Christmas Offers:

Invion Limited is at the forefront of developing Photosoft™ technology, a next-generation Photodynamic Therapy (PDT) for treating various cancers, atherosclerosis, and infectious diseases. The technology, licensed for use in multiple regions excluding some Asia Pacific countries and others, is currently undergoing research and clinical trials funded by RMW Cho Group Limited. Invion’s innovative approach to PDT offers a less invasive option with minimal side effects, providing hope against antibiotic-resistant pathogens and aiming for complete tumor regression.

For further insights into AU:IVX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskInvion Appoints Renowned Scientist to Boost Cancer Research
TipRanks Australian Auto-Generated NewsdeskInvion Explores Expansion Amidst New Share Issuance
TipRanks Australian Auto-Generated NewsdeskInvion Limited Issues Share Options to Director
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App